Arabica coffee bean
Star0
Explore a selection of our essential drug information below, or:
Identification
- Summary
Arabica coffee bean is an extract from Arabica coffee bean used in allergy testing.
- Generic Name
- Arabica coffee bean
- DrugBank Accession Number
- DB10666
- Background
Arabica coffee bean allergenic extract is used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Arabian coffee bean
- Arabica coffee bean
- Arabica coffee bean allergenic extract
- Coffea arabica (coffee) seed extract
- Coffea arabica (coffee) seed powder
- Coffea arabica seed
- Coffea arabica seed, roasted, extract
- Coffea bourbonica seed
- Coffea corymbulosa seed
- Coffea cruda
- Coffea laurifolia seed
- Coffea moka seed
- Coffea sundana seed
- Coffea vulgaris seed
- Coffee (concentrate pure)
- Coffee, green
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Coffee Injection, solution 0.1 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Coffee Injection, solution 0.1 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Coffee Injection, solution 0.1 g/1mL Percutaneous ALK-Abello, Inc. 1998-02-23 Not applicable US Coffee Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Coffee Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Antigen Laboratories, Inc. 1974-03-23 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Anti White Hair Essence Arabica coffee bean (9 mg/30mL) + Peptide YY (1-36) (6 mg/30mL) + Pyridoxine (6 mg/30mL) + Tocopherol (6 mg/30mL) Liquid Cutaneous Shantou Youjia E-Commerce Co., Ltd. 2024-02-01 2024-12-31 US Cream Arabica coffee bean (7.5 g/50g) + Glycerin (12.5 g/50g) + Hyaluronic acid (12.5 g/50g) + Vitamin A (10 g/50g) Cream Cutaneous Shantou Youjia E-Commerce Co., Ltd. 2024-02-01 2024-12-31 US Cream Arabica coffee bean (11.4 g/57g) + Aloe vera leaf (8.55 g/57g) + Sodium hyaluronate (8.55 g/57g) Cream Cutaneous Shantou Youjia E-Commerce Co.,Ltd. 2024-02-01 2024-12-31 US Gel Arabica coffee bean (2 mg/10mg) + Nicotinamide (1.5 mg/10mg) + Tocopherol (1 mg/10mg) Gel Cutaneous Shantou Youjia E-Commerce Co.,Ltd. 2024-02-01 2024-12-31 US Prostate Relief Drops Arabica coffee bean (6 mg/30mL) + Acetylcarnitine (6 mg/30mL) + Capsicum (6 mg/30mL) + White pepper (3 mg/30mL) Liquid Oral ShantouYoujiaE-CommerceCo.,Ltd. 2024-02-01 2024-12-31 US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 3SW678MX72
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Liquid Cutaneous Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Injection, solution Percutaneous 0.1 g/1mL Gel Cutaneous Liquid Oral Cream Cutaneous - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:04 / Updated at June 12, 2020 16:53